FDA for medical devices offers more clear de novo pathway
The US Food and Drug Administration (FDA) has proposed revisions to the de novo pathway in order to make medical device classification more efficient and transparent. The De Novo pathway is used to review new, low-to-moderate risk devices and determine predicates that assure certain safety and effectiveness measures.The regulatory agency has published the new de […]
FDA for medical devices offers more clear de novo pathway Read More »










